Compare · CARL vs MDLN
CARL vs MDLN
Side-by-side comparison of Carlsmed Inc. (CARL) and Medline Inc. (MDLN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CARL and MDLN operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $48.08B, about 126.2x CARL ($380.9M).
- Over the past year, CARL is down 6.0% and MDLN is down 11.8% - CARL leads by 5.8 points.
- CARL has been more active in the news (12 items in the past 4 weeks vs 7 for MDLN).
- MDLN has more recent analyst coverage (25 ratings vs 6 for CARL).
PerformanceCARL+7.61%MDLN-11.77%
2025-12-17+0.00%2026-10-16
- Company
- Carlsmed Inc.
- Medline Inc.
- Price
- $13.44-4.21%
- $35.95-1.74%
- Market cap
- $380.9M
- $48.08B
- 1M return
- -12.50%
- +11.97%
- 1Y return
- -6.01%
- -11.77%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2025
- 2025
- News (4w)
- 12
- 7
- Recent ratings
- 6
- 25
Latest CARL
- SEC Form 144 filed by Carlsmed Inc.
- Carlsmed Launches aprevo® Lumbar Bi-lateral Posterior System
- SEC Form 4 filed by Carlsmed Inc.
- Carlsmed, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Chief Operating Officer Bertolini Jeffrey sold $3,400 worth of shares (243 units at $13.99) as part of a pre-agreed trading plan and exercised 243 shares at a strike of $2.23 (SEC Form 4)
- SEC Form S-8 filed by Carlsmed Inc.
- Carlsmed Appoints Tony Jarc as Chief Product and AI Officer
- New insider Kamocsay Jennifer claimed ownership of 56,222 shares (SEC Form 3)
- CFO, Treasurer Heppenstall Richard was granted 89,286 shares (SEC Form 4)
- SEC Form 3 filed by new insider Heppenstall Richard
Latest MDLN
- SEC Form 8-K filed by Medline Inc.
- Medline to build Midwestern network with new 800,000-square-foot facility in Van Buren Township, Mich.
- SEC Form 4 filed by Medline Inc.
- Medline launches enhanced TrackPoint™ to simplify inventory management for post-acute care
- SEC Form 4 filed by Medline Inc.
- MEDLINE INC. MDLN INVESTORS: Contact Kirby McInerney LLP About the Firm’s Securities Investigation Following 12.8% Share Drop
- Medline to report third quarter 2026 results on November 4, 2026
- INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Medline Inc. to Contact Law Firm
- Medline announces participation in the Morgan Stanley 24th Annual Global Healthcare Conference
- SEC Form 4 filed by Chief Executive Officer Boyle James M